Meeting
2020 ASCO Virtual Scientific Program
Malignancies associated with DPP4 inhibitors and GLP1 receptor agonists: Data from a large real-world database.
Authors
Jiasheng Wang
MetroHealth Medical Center, Cleveland, OH
Jiasheng Wang , Chang H. Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Risk Reduction, and Genetics
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Etiology/Epidemiology
Citation
J Clin Oncol 38: 2020 (suppl; abstr 1567)
DOI
10.1200/JCO.2020.38.15_suppl.1567
Abstract #
1567
Poster Bd #
59
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
A multicenter retrospective analysis examining the effect of dipeptidyl protease 4 (DPP4) inhibitors on progression-free survival in patients with prostate cancer.
First Author: Kelsey Pan
Poster
2020 ASCO Virtual Scientific Program
Obesity and metabolic syndrome correlate with a higher risk of biochemical recurrence in high risk and intermediate risk prostate cancer patients who underwent robotic-assisted laparoscopic prostatectomy.
First Author: Shifeng Mao
Poster
2019 Breakthrough
Metformin, aspirin and statin and risk of cancer: A population-based study in Thailand.
First Author: Songporn Oranratnachai
Poster
2019 ASCO Annual Meeting
Insulin resistance measured by the triglyceride-glucose index and risk of obesity-related cancers: An epidemiological investigation in more than 500,000 individuals.
First Author: Josef Fritz